BrainReference is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.
We aim to provide consumers with helpful, in-depth information about brain health products. Whether we make money or not on a certain page does not influence the core mission of our writers and medical reviewers, which is to publish content that is accurate and informative.
All product names, logos, and brands are the property of their respective owners.
For more information, see our full Advertising Disclosure
Strattera Review – 13 Things You Should Know Before You Buy
Strattera (Atomoxetine Hydrochloride) is an alternative to the stimulant ADHD prescriptions regularly used to treat symptoms of attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) in children ages 6-12, adolescents, and adults.
Our Strattera review will concentrate on answers to some of the most commonly asked questions about this ADD/ADHD medication, including questions regarding claimed benefits, potential side effects, effectiveness, testimonials, and possible alternatives.
1) Strattera Quick Facts
Strattera (Atomoxetine) is a selective norepinephrine reuptake inhibitor (SNRI) medicine, and it was the first non-stimulant prescription allowed for ADD/ADHD treatment in the United States by the Food and Drug Administration (FDA).
In most cases, the standard treatment for ADD/ADHD includes stimulant prescription medication. However, Strattera is a safer alternative for patients who cannot tolerate or don’t experience the desired effects of stimulant drugs.
2) How Did Strattera Start?
Atomoxetine, marketed under the brand name Strattera amongst others, was accepted for medical use in the U.S. in 2002. Four years later, in 2016, Atomoxetine was the 245th most prescribed medication in the United States, with more than 2 million prescriptions.
Strattera is produced by Eli Lilly and Company, an American pharmaceutical company with headquarters in Indianapolis, Indiana, and offices and facilities in 18 countries, including United Kingdom, Austria, Italy, Belgium, Spain, and Brazil. Its products are sold in approximately 125 countries. Eli Lilly was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist, and veteran of the American Civil War.
Lilly is currently the biggest producer of psychiatric prescriptions and makes a wide range of prescription drugs such as Dolophine (Methadone), Prozac (Fluoxetine), Zyprexa (Olanzapine), and Cymbalta (Duloxetine).
Eli Lilly and Company contact information:
- Phone: +1-317-276-2000;
- Address: Indianapolis, Indiana 46285 United States;
- Website: lilly.com.
3) Strattera Nutrition Facts
Strattera contains the following active ingredients: Atomoxetine 10 mg.
Atomoxetine is a synthetic compound that affects chemicals in the brain and nerves that contribute to impulse control and hyperactivity. Generally, Atomoxetine is utilized to treat attention deficit hyperactivity disorder (ADHD) and attention deficit disorder (ADD), and it’s recommended for use in children, adolescents, and adults. Yet, Atomoxetine’s efficacy has not been analyzed in infants under six years old.
4) Is Strattera Right for You?
While stimulants such as Concerta and Adderall are the “go-to” prescribed medicines for the treatment of attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD), they are not always well-tolerated. These powerful stimulants can cause many unwanted adverse effects such as weight loss, irritability, and insomnia. Stimulants like Concerta, Ritalin, and Adderall have also been linked to cardiovascular side effects and the risk of dependence.
There is an alternative, though: Atomoxetine, known by its brand name, Strattera, is the only non-stimulant ADD/ADHD prescription sold in the United States. Usually, Strattera is prescribed as part of a more complex treatment plan that includes social, psychological, and other treatments.
Atomoxetine is one of the most researched and studied chemical compounds, both for safeness and effectiveness. Clinical studies have determined that it is safe and effective for long-term use, although not as effective or quick-acting as stimulants.
One good example of such a study is the 2008 clinical study in the Journal of Attention Disorders. The research was conducted on nearly 400 adult volunteers with ADD/ADHD who took Strattera for up to four years. The participants noticed their ADD/ADHD symptoms lessened by more than 30%, and the authors reported no unforeseen adverse effects.
5) What Strattera Does?
Some Strattera claimed benefits include:
- Improve attention span;
- Decrease hyperactivity;
- Reduce impulsive behaviors.
6) Potential Strattera Effects
Strattera can cause mild and moderate side effects, including:
- Abdominal pain
- Weight loss
- Aggressive behavior
- Decreased appetite
- Dry mouth
- Excessive sweating
- Decreased sex drive
- Vision changes, such as blurry vision, double vision, and pupil dilation (enlarged pupils)
- Increased blood pressure
- Increased heart rate
Strattera may also induce thoughts of suicide, primarily in children and teens.
Some severe adverse effects can occur while taking Strattera. These severe side effects may include:
- Chest pain
- Shortness of breath
- Itchy skin
- Fast or pounding heartbeat
- Dizziness or faintness
- Trouble speaking
- Pain in the upper right part of the belly
- Weakness or numbness of an arm or leg
- Yellowing of the skin or eyes
- Dark urine
- Hallucination (seeing things or hearing voices that do not exist)
- Unexplained flu-like symptoms
- Trouble swallowing or breathing
- Swelling in the face, tongue, lips, throat, hands, feet, eyes, ankles, or lower legs
- Rash or hives
- Abnormal thoughts
- Erection that lasts for several hours or longer
7) What You Need to Know Before Taking Strattera
As it’s the case with all prescription medications, there are quite a few warnings and precautions when taking Strattera (Atomoxetine).
Who should NOT take Strattera:
- People who have used an MAO inhibitor (i.e., methylene blue injection, isocarboxazid, phenelzine, rasagiline, linezolid, selegiline, and tranylcypromine) in the past 14 days;
- People who are allergic to Atomoxetine;
- People with severe blood vessel or heart problems.
Strattera should not be taken by pregnant or nursing women unless recommended by a medical doctor. It is not known whether Atomoxetine passes into breast milk or if it could affect a nursing baby.
Strattera is not approved as a treatment for anyone younger than six years old.
8) Where to Buy Strattera in the United States?
Strattera (Atomoxetine) is a prescription medication. That means it can’t, and it shouldn’t be bought from unapproved stores. It is available, however, at most drugstores.
9) Strattera Cost
Strattera oral capsule 10 mg costs around $420 for a supply of 30 capsules. The price may vary depending on the pharmacy you are buying from, and based on capsule strength (10 mg, 25 mg, 40 mg, 60 mg, 80 mg, and 100 mg).
10) Alternatives to Strattera
One of the most common questions we have received from our readers is, “are there alternatives to Strattera?” However, because Strattera (Atomoxetine) is a prescription drug, we can only review prescription medicines as potential alternatives. We don’t advocate substituting a treatment directed by your medical doctor with an over-the-counter dietary supplement.
Vyvanse (Lisdexamfetamine) it’s an amphetamine chemical compound. Like Strattera, Vyvanse also alters brain chemicals. However, it targets both norepinephrine and dopamine. It’s speculated that this prescription medicine increases dopamine levels in the brain and improves the rate at which norepinephrine is released. As a result, more of these chemicals are available to stimulate the brain, which helps increase focus and attention.
Kapvay (Clonidine E.R.E.R.) is another powerful non-stimulant prescription drug approved for children ages 6 to 17. However, while mostly used in children, Kapvay may also be prescribed to adults. Kapvay (Clonidine E.R.E.R.) affects particular areas in the brain, numerous clinical studies concluding that Clonidine E.R.E.R. may improve impulse control, working memory, attention, and lower distractibility.
11) How to Use Strattera
The standard initial dose of Strattera (Atomoxetine) is usually 10 mg, one or two times a day (early morning and late afternoon/early evening). Taking it at the same time each day will have the best effect. It will also help you remember when to take it. It does not matter if you take Strattera before or after food.
12) What Customers Say About Strattera
"It does work. But, give it two or three weeks. You will feel weird at the beginning and a little nauseous. It goes away. I do feel like I concentrate better and focus longer. Be careful with caffeine! It makes caffeine much stronger and last longer." [Read full review]
"At 34, I started Ritalin. It had an up & down effect. At 46, I began Strattera. I hated it. Gained 35 lbs; anxiety soared; was fatigued & lethargic. My current dose is 60mg 2x/day. I never lost weight, but I feel normal. I don't limit caffeine intake. I drink tea, no coffee. Anxiety & depression are better w/Strattera." [Read full review]
"I was taking Concerta but had to go down from 54mg to 30mg because of side effects. With Concerta, I said everything that was on my mind, and I still could not concentrate enough as my mind was all over the place." [Read full review]
"Game changer for me. 60mg for ~3y. The not magic bullet, but without it, I couldn't be self-employed. I still lose days immobilized or where all I can do is a few emails but compared to weeks of incapacity without it." [Read full review]
13) Bottom Line – Does It Really Work?
Strattera (Atomoxetine) is a potent non-stimulant prescription drug that has been shown to help many people. However, based on your condition, Strattera may or may not be the right medicine for you. Be straightforward with your doctor when you talk about your current mental and physical health and your health history.
We strongly recommend taking Strattera precisely as directed by your doctor to treat your mental health problem. Regularly, medications for mental health conditions are part of an overall treatment plan that includes counseling and other therapies.
Talk with your doctor about how long it may take for Strattera to make a difference in how you feel. If it seems like the drug isn’t working, tell your physician. There may be other alternatives to treat your condition.Looking for greater attention and focus? Strattera has many benefits, but there are products available that may be more helpful in achieving increased focus and attention.
An excellent calm, focus, and attention supplement in 2021 is HCF® Happy, Calm & Focused. Trusted for over 10 years with the highest quality, simple, clean ingredients for effectively nourishing the brain, the company has been dedicated to only the foundational building blocks of life; amino acids, minerals, and vitamins, unlike the common high-dose 'all-in-one' or artificially stimulating/inhibiting herbal ingredients found on the market today for supporting calm and focus.
|Strattera Customers Also Purchased:||
10+ Yrs Proven
|HCF Happy, Calm & Focused
Common Strattera Questions and Answers
Strattera contains the following active ingredients: Atomoxetine 10 mg.
Strattera (generic: Atomoxetine) is a safer, non-stimulant alternative to the prescriptions regularly used to treat symptoms of attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) in children ages 6-12, adolescents, and adults.
Strattera can cause mild, moderate, and severe side effects, including abdominal pain, dizziness or faintness, insomnia, weight loss, irritability, yellowing of the skin or eyes, dark urine, depression, diarrhea, increased blood pressure, aggressive behavior, weakness or numbness of an arm or leg, decreased appetite, agitation, increased heart rate, nausea, constipation, dry mouth, excessive sweating, decreased sex drive, anxiety, vision changes (i.e., blurry vision, double vision, and pupil dilation), dizziness, unexplained flu-like symptoms, hoarseness, headaches, restlessness, tiredness, tremor, chest pain, shortness of breath, fast or pounding heartbeat, seizures, trouble speaking, pain in the upper right part of the belly, vomiting, hallucination, trouble swallowing or breathing, swelling, itchy skin, rash or hives, abnormal thoughts, and an erection that lasts for several hours or longer.
As a prescription medication, Strattera is available for purchase at most pharmacies.
Strattera oral capsule 10 mg costs around $420 for a supply of 30 capsules.
Strattera is frequently advertised as a safer alternative for patients who cannot tolerate or don't experience the desired effects of stimulant drugs.
Strattera (Atomoxetine) has become a second-line and, in some cases, first-line treatment in children and adults with ADD/ADHD because of its effectiveness and classification as a non-stimulant. However, clinical trials have reported that the overall efficacy of Atomoxetine has not been as extensive as that reported of stimulants.
As with all prescription medication, we advise caution when taking Strattera with other prescription medication or over-the-counter dietary supplements. Drugs that may interact with Strattera include Wellbutrin, Anafranil, Prozac, Marplan, Nardil, Eldepryl, Emsam, and Zelapar.
Many other prescription medications may affect the way Strattera (Atomoxetine) works. The drug could also affect other medicines. It's imperative to let your physician know about everything you are taking, including any over-the-counter (OTC) medications, herbs, dietary supplements, or illegal drugs.
Strattera is approved for use in children ages 6 to 12, adolescents, and adults.
Strattera only contains one active ingredient in the form of Atomoxetine. This chemical compound was studied across multiple clinical trials, and it was shown to cause mild, moderate, and even severe side effects in some patients.
You should not be taking Strattera unless it was prescribed to you by a physician.
There are no testimonials with Strattera during breastfeeding, although clinical research from the manufacturer noticed no serious adverse effects in breastfed infants. However, an alternate prescription or dietary supplement may be preferred, especially while nursing a newborn or preterm infant.
Take Strattera at the same time each day, with a full glass of water. It's usually recommended to take once daily in the morning, or two times per day in the morning and late afternoon.
You can contact the Eli Lilly and Company customer support department by phone at +1-317-276-2000, by mail at Indianapolis, Indiana 46285 United States, or by using the Contact Us form available on their official website.
As Strattera is a prescription medication, please discuss any possible returns or refunds with the doctor who prescribed it to you.
Many customers complain about Strattera's adverse effects and
Compared to other similar prescription medicines, Strattera (Atomoxetine) has generally received positive reviews from real patients. Because it's non-habit forming and non-stimulant, Strattera is well regarded and widely used as a treatment for ADD/ADHD.
Strattera is produced and marketed by U.S.-based Eli Lilly and Company.
- uspl.lilly.com. Strattera. Retrieved on February 6, 2020.
- additudemag. Strattera. Retrieved on February 6, 2020.
- accessdata.fda.gov. Strattera (atomoxetine HCl). Retrieved on February 6, 2020.
- drugs.com. Atomoxetine Hydrochloride. Retrieved on February 6, 2020.
- clincalc.com. ClinCalc DrugStats Database. Retrieved on February 6, 2020.
- lilly.com. Eli Lilly and Company official website. Retrieved on February 6, 2020.
- pi.lilly.com. Strattera (atomoxetine hydrochloride) Capsules for Oral Use. Full Prescribing Information (PDF). Retrieved on February 6, 2020. 8) ncbi.nlm.nih.gov. Simpson D. and Plosker GL. - Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. Published in 2004.
- ncbi.nlm.nih.gov. Simpson D. and Plosker GL. - Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. Published in 2004.
- dovepress.com. - Ann C. Childress - A critical appraisal of Atomoxetine in the management of ADHD. Published online on November 9, 2015.
- onlinelibrary.wiley.com. Linda A. Wietecha, David B. Clemow, Andrew S. Buchanan, Joel L. Young, Elias H. Sarkis, and Robert L. Findling - Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials. Published online on February 28, 2016.
- ncbi.nlm.nih.gov. Arthur N. Westover and Ethan A. Halm - Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review. Published in 2012.
- oxfordtreatment.com. Oxford Treatment Center Editorial Staff - The Truth Behind Adderall and Heart Problems. Retrieved on February 6, 2020.
- drugabuse.gov. Prescription Stimulants. Retrieved on February 6, 2020.
- ncbi.nlm.nih.gov. Adler LA, Spencer TJ, Milton DR, Moore RJ, and Michelson D. - Long-term, open-label study of the safety and efficacy of Atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. Published in March 2005.
- ncbi.nlm.nih.gov. Michael R. Kohn, Tracey W. Tsang, and Simon D. Clarke - Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder. Published online on November 5, 2012.
- ncbi.nlm.nih.gov. Rana Dadashova and Peter H. Silverstone - Off-label use of Atomoxetine in adults: is it safe? Published online on September 24, 2012.
- health.harvard.edu. Michael Craig Miller - Questions & Answers: Is Strattera dangerous? Retrieved on February 6, 2020.
- vyvanse.com. Official Vyvanse website. Retrieved on February 6, 2020.
- ncbi.nlm.nih.gov. Xue Ming, Martha Mulvey, Sharanya Mohanty, and Viraj Patel - Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders. Published online on September 30, 2011.
- ncbi.nlm.nih.gov. Scott H. Kollins, Rakesh Jain, Matthew Brams, Scott Segal, Robert L. Findling, Sharon B. Wigal, and Moise Khayrallah - Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD. Published in June 2011.
- medsafe.govt.nz. Strattera. Retrieved on February 6, 2020.